Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Wockhardt clinical trials
The registry lists 43 studies whose lead sponsor is Wockhardt or one of 1 company grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Wockhardt studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Wockhardt.
- Wockhardt39 studiesSame company
Something wrong?
- 4 studies →
Studies
Recruiting first, then most recently updated. Showing 43 of 43.
- Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaNot yet recruitingNCT07885891Phase 3
- This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Hospitalized Adult Patients With Complicated Urinary Tract Infection or Acute PyelonephritisNot yet recruitingNCT07840105Phase 2
- Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Not yet recruitingNCT03630081Phase 3
- Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)CompletedNCT04979806Phase 3
- Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.CompletedNCT07247942Phase 1
- MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy AdultsCompletedNCT02674347Phase 1
- A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.CompletedNCT06806995Phase 1
- Immunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsTerminatedNCT01308437Phase 3
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771CompletedNCT05640531Phase 1
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349CompletedNCT04874324Phase 1
- Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03405064Phase 3
- Phase II Study of Oral Nafithromycin in CABPCompletedNCT02903836Phase 2
- Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic PatientsWithdrawnNCT01352663Phase 3
- Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous NafithromycinCompletedNCT03981887Phase 1
- Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult VolunteersCompletedNCT03979859Phase 1
- The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult VolunteersCompletedNCT03926962Phase 1
- Plasma and Intrapulmonary Concentrations Study of WCK 5222CompletedNCT03630094Phase 1
- To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)CompletedNCT03622008Phase 1
- To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal ImpairmentCompletedNCT02942810Phase 1
- A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult SubjectsCompletedNCT02770404Phase 1
- Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy VolunteersCompletedNCT03554304Phase 1
- A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal ImpairmentCompletedNCT02709382Phase 1
- MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy VolunteersCompletedNCT02707107Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With CefepimeCompletedNCT02532140Phase 1
- Pharmacokinetics of WCK 2349 In Patients With Hepatic ImpairmentCompletedNCT02244827Phase 1
- Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health VolunteersCompletedNCT02217930Phase 1
- Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human SubjectsCompletedNCT02253342Phase 1
- Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human SubjectsCompletedNCT02453529Phase 1
- Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human VolunteersCompletedNCT01875939Phase 1
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy SubjectsWithdrawnNCT01400789Phase 1
- Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DMCompletedNCT01357603Phase 1
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy SubjectsWithdrawnNCT01399255Phase 1
- Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsWithdrawnNCT01398670Phase 3
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy SubjectsWithdrawnNCT01400802Phase 1
- Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy SubjectsCompletedNCT00772265Phase 1
- Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 DiabeticsCompletedNCT00752180Phase 1
- Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy SubjectsCompletedNCT01358435Phase 1
- Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.CompletedNCT00596063Phase 1
- Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.CompletedNCT00719108Phase 1
- Symptomatic Efficacy of Diacerein in Knee OsteoarthritisCompletedNCT00445276Phase 4
Sponsor listed in the registry: Laboratoires NEGMA · First submitted before Laboratoires NEGMA became part of Wockhardt
- Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee OsteoarthritisCompletedNCT00440661Phase 4
Sponsor listed in the registry: Laboratoires NEGMA · First submitted before Laboratoires NEGMA became part of Wockhardt
- Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the KneeStatus unknownNCT01009671Phase 3
Sponsor listed in the registry: Laboratoires NEGMA · First submitted after Laboratoires NEGMA became part of Wockhardt
- Chondromodulating Effect of Diacerein in Osteoarthritis of the HipCompletedNCT00451360Phase 3
Sponsor listed in the registry: Laboratoires NEGMA · First submitted before Laboratoires NEGMA became part of Wockhardt